Emergency reversal of anticoagulation: from theory to real use of prothrombin complex concentrates. A retrospective Italian experience. (opens new window)

Barillari G, Pasca S, Barillari A, De Angelis V.

Avots‎: Blood Transfus 2012;10(1):87-94.

Raksts indeksēts‎: PubMed 22044952

DOI‎: 10.2450/2011.0030-11

https://www.ncbi.nlm.nih.gov/pubmed/22044952 (opens new window)

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (opens new window)

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, Dunn AS, Kunz R; American College of Chest Physicians.

Avots‎: Chest 2012;141(2 Suppl):e326S-50S.

Raksts indeksēts‎: PubMed 22315266

DOI‎: 10.1378/chest.11-2298

https://www.ncbi.nlm.nih.gov/pubmed/22315266 (opens new window)

Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial. (opens new window)

Goldstein JN, Refaai MA, Milling TJ Jr, Lewis B, Goldberg-Alberts R, Hug BA, Sarode R.

Avots‎: Lancet 2015;385(9982):2077-87.

Raksts indeksēts‎: PubMed 25728933

DOI‎: 10.1016/S0140-6736(14)61685-8

https://www.ncbi.nlm.nih.gov/pubmed/25728933 (opens new window)

Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. (opens new window)

Hanke AA, Joch C, Görlinger K.

Avots‎: Br J Anaesth 2013;110(5):764-72.

Raksts indeksēts‎: PubMed 23335567

DOI‎: 10.1093/bja/aes501

https://www.ncbi.nlm.nih.gov/pubmed/23335567 (opens new window)

Emergency reversal of warfarin anticoagulation. (opens new window)

Lin Y, Callum J.

Avots‎: CMAJ 2010;182(18):2004.

Raksts indeksēts‎: PubMed 21078740

DOI‎: 10.1503/cmaj.100983

https://www.ncbi.nlm.nih.gov/pubmed/21078740 (opens new window)

Recent advances in the development of specific antidotes for target-specific oral anticoagulants. (opens new window)

Mo Y, Yam FK.

Avots‎: Pharmacotherapy 2015;35(2):198-207.

Raksts indeksēts‎: PubMed 25644580

DOI‎: 10.1002/phar.1532

https://www.ncbi.nlm.nih.gov/pubmed/25644580 (opens new window)

Idarucizumab for dabigatran reversal - full cohort analysis. (opens new window)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Avots‎: N Engl J Med 2017;377(5):431-41.

Raksts indeksēts‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (opens new window)

Oral anticoagulation in surgical procedures: risks and recommendations. (opens new window)

Torn M, Rosendaal FR.

Avots‎: Br J Haematol 2003;123(4):676-82.

Raksts indeksēts‎: PubMed 14616972

https://www.ncbi.nlm.nih.gov/pubmed/14616972 (opens new window)